Akademik Veri Yönetim Sistemi
Turkish Journal of Gastroenterology, cilt.9, sa.4, ss.340-344, 1998 (Scopus, TRDizin)
Injection sclerotherapy of bleeding esophageal varices is undoubtedly beneficial but it is associated with a substantial local and systemic complication rate and variceal rebleeding is common during the treatment period before variceal obliteration is achieved. Endoscopic banding ligation, a different form of endoscopic treatment for esophageal varices, may be safer. We compared the effectiveness and safety of the two techniques. Among the patients in whom variceal eradication was achieved, there was no significant difference between the two groups in mean time of variceal eradication and number of sessions although ligation therapy offered shorter eradication time [3,4 (1-4) months vs 2,4 (1-4,5) months respectively, p > 0.05] and in fewer sessions [4,5 (1-7) vs 5, 6 (1-18) respectively, p > 0.05)] than sclerotherapy. Rebleeding tended to be less with banding ligation than sclerotherapy [four patients (10%) vs nine patients (32%) respectively, p < 0.05]. There was no difference in survival between the groups. Complications were less common in the ligation group [two patients (4,6%) vs seven patients (25%) respectively, p < 0.05]. In the patients with cirrhosis who have esophageal varices, banding ligation is a safe and effective technique which obliterates varices quickly and with a lower rebleeding rate than injection sclerotherapy.